Skip to main content
. 2016 Aug 23;49(2):484–493. doi: 10.4143/crt.2016.246

Fig. 1.

Fig. 1.

The 10-year locoregional recurrence-free survival rate for all patients (A), between those aged < 40 years and ≥ 40 years (B), between luminal and nonluminal subtypes (C), and between biological subtypes (D).